Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both
L. Michael Prisant, MD, FACC*,*,
Kevin L. Thomas, MD ,
Eldrin F. Lewis, MD, MPH ,
Zhen Huang, MS ,
Gary S. Francis, MD, FACC ,
W. Douglas Weaver, MD, FACC||,
Marc A. Pfeffer, MD, PhD, FACC ,
John J.V. McMurray, MD, FACC¶,
Robert M. Califf, MD, MACC and
Eric J. Velazquez, MD, FACC
* Hypertension and Clinical Pharmacology, Medical College of Georgia, Augusta, Georgia
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
Brigham and Women's Hospital, Boston, Massachusetts
The Cleveland Clinic Foundation, Cleveland, Ohio
|| Henry Ford Heart and Vascular Institute, Detroit, Michigan
¶ Western Infirmary, Glasgow, Scotland.

View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Adjusted 3-Year Rates of CV Events by Race
The adjusted cardiovascular event rates are not significantly different between African Americans and white patients. CHF = congestive heart failure; CI = confidence interval; CV = cardiovascular; MI = myocardial infarction.
|
|
|